Cargando…

Activator-blocker model of transcriptional regulation by pioneer-like factors

Zygotic genome activation (ZGA) in the development of flies, fish, frogs and mammals depends on pioneer-like transcription factors (TFs). Those TFs create open chromatin regions, promote histone acetylation on enhancers, and activate transcription. Here, we use the panel of single, double and triple...

Descripción completa

Detalles Bibliográficos
Autores principales: Riesle, Aileen Julia, Gao, Meijiang, Rosenblatt, Marcus, Hermes, Jacques, Hass, Helge, Gebhard, Anna, Veil, Marina, Grüning, Björn, Timmer, Jens, Onichtchouk, Daria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502082/
https://www.ncbi.nlm.nih.gov/pubmed/37709752
http://dx.doi.org/10.1038/s41467-023-41507-z
_version_ 1785106242787606528
author Riesle, Aileen Julia
Gao, Meijiang
Rosenblatt, Marcus
Hermes, Jacques
Hass, Helge
Gebhard, Anna
Veil, Marina
Grüning, Björn
Timmer, Jens
Onichtchouk, Daria
author_facet Riesle, Aileen Julia
Gao, Meijiang
Rosenblatt, Marcus
Hermes, Jacques
Hass, Helge
Gebhard, Anna
Veil, Marina
Grüning, Björn
Timmer, Jens
Onichtchouk, Daria
author_sort Riesle, Aileen Julia
collection PubMed
description Zygotic genome activation (ZGA) in the development of flies, fish, frogs and mammals depends on pioneer-like transcription factors (TFs). Those TFs create open chromatin regions, promote histone acetylation on enhancers, and activate transcription. Here, we use the panel of single, double and triple mutants for zebrafish genome activators Pou5f3, Sox19b and Nanog, multi-omics and mathematical modeling to investigate the combinatorial mechanisms of genome activation. We show that Pou5f3 and Nanog act differently on synergistic and antagonistic enhancer types. Pou5f3 and Nanog both bind as pioneer-like TFs on synergistic enhancers, promote histone acetylation and activate transcription. Antagonistic enhancers are activated by binding of one of these factors. The other TF binds as non-pioneer-like TF, competes with the activator and blocks all its effects, partially or completely. This activator-blocker mechanism mutually restricts widespread transcriptional activation by Pou5f3 and Nanog and prevents premature expression of late developmental regulators in the early embryo.
format Online
Article
Text
id pubmed-10502082
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105020822023-09-16 Activator-blocker model of transcriptional regulation by pioneer-like factors Riesle, Aileen Julia Gao, Meijiang Rosenblatt, Marcus Hermes, Jacques Hass, Helge Gebhard, Anna Veil, Marina Grüning, Björn Timmer, Jens Onichtchouk, Daria Nat Commun Article Zygotic genome activation (ZGA) in the development of flies, fish, frogs and mammals depends on pioneer-like transcription factors (TFs). Those TFs create open chromatin regions, promote histone acetylation on enhancers, and activate transcription. Here, we use the panel of single, double and triple mutants for zebrafish genome activators Pou5f3, Sox19b and Nanog, multi-omics and mathematical modeling to investigate the combinatorial mechanisms of genome activation. We show that Pou5f3 and Nanog act differently on synergistic and antagonistic enhancer types. Pou5f3 and Nanog both bind as pioneer-like TFs on synergistic enhancers, promote histone acetylation and activate transcription. Antagonistic enhancers are activated by binding of one of these factors. The other TF binds as non-pioneer-like TF, competes with the activator and blocks all its effects, partially or completely. This activator-blocker mechanism mutually restricts widespread transcriptional activation by Pou5f3 and Nanog and prevents premature expression of late developmental regulators in the early embryo. Nature Publishing Group UK 2023-09-14 /pmc/articles/PMC10502082/ /pubmed/37709752 http://dx.doi.org/10.1038/s41467-023-41507-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Riesle, Aileen Julia
Gao, Meijiang
Rosenblatt, Marcus
Hermes, Jacques
Hass, Helge
Gebhard, Anna
Veil, Marina
Grüning, Björn
Timmer, Jens
Onichtchouk, Daria
Activator-blocker model of transcriptional regulation by pioneer-like factors
title Activator-blocker model of transcriptional regulation by pioneer-like factors
title_full Activator-blocker model of transcriptional regulation by pioneer-like factors
title_fullStr Activator-blocker model of transcriptional regulation by pioneer-like factors
title_full_unstemmed Activator-blocker model of transcriptional regulation by pioneer-like factors
title_short Activator-blocker model of transcriptional regulation by pioneer-like factors
title_sort activator-blocker model of transcriptional regulation by pioneer-like factors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502082/
https://www.ncbi.nlm.nih.gov/pubmed/37709752
http://dx.doi.org/10.1038/s41467-023-41507-z
work_keys_str_mv AT riesleaileenjulia activatorblockermodeloftranscriptionalregulationbypioneerlikefactors
AT gaomeijiang activatorblockermodeloftranscriptionalregulationbypioneerlikefactors
AT rosenblattmarcus activatorblockermodeloftranscriptionalregulationbypioneerlikefactors
AT hermesjacques activatorblockermodeloftranscriptionalregulationbypioneerlikefactors
AT hasshelge activatorblockermodeloftranscriptionalregulationbypioneerlikefactors
AT gebhardanna activatorblockermodeloftranscriptionalregulationbypioneerlikefactors
AT veilmarina activatorblockermodeloftranscriptionalregulationbypioneerlikefactors
AT gruningbjorn activatorblockermodeloftranscriptionalregulationbypioneerlikefactors
AT timmerjens activatorblockermodeloftranscriptionalregulationbypioneerlikefactors
AT onichtchoukdaria activatorblockermodeloftranscriptionalregulationbypioneerlikefactors